Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data

Author： Rajagopalan Krithika  

Publisher： Informa Healthcare

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.7, 2013-07, pp. : 951-961

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia

By Ascher-Svanum Haya   Stensland Michael D.   Peng Xiaomei   Faries Douglas E.   Stauffer Virginia L.   Osuntokun Olawale O.   Kane John M.  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 115-122

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study

By King D.   Knapp M.   Thomas P.   Razzouk D.   Loze J.-Y.   Kan H.J.   van Baardewijk M.  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 365-374

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents

By Kim Eun Young   Chang Sung Man   Shim Joo Cheol   Joo Eun Jeong   Kim Jae Jin   Kim Yong Sik   Ahn Yong Min  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1231-1240

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK**

By Davies Andrew   Vardeva Kawitha   Loze Jean-Yves   L’’Italien Gilbert J.   Sennfalt Karin   Baardewijk Marc van  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3275-3285

Informa Healthcare

Access to resources Recommend Favorite

A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA)

By Wolf Jürgen   Janssen Firmin   Lublin Henrik   Salokangas Raimo KR   Allain Hervé   Smeraldi Enrico   Bernardo Miguel   Millar Helen   Pans Miranda   Adelbrecht Christine   Laughton Jim   Werner Christian   Maier Wolfgang  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2313-2323

Informa Healthcare

Access to resources Recommend Favorite